Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Atrial Fibrillation or Flutter

Interventions

DRUG

Vanoxerine HCl

DRUG

Placebo

Trial Locations (16)

Littleton

Washington D.C.

Iowa City

St Louis

Plovdiv

Sofia

Budapest

Hódmezővásárhely

Pécs

Rókus

Zalaegerszeg

Ashkelon

Safed

Moscow

Saint Petersburg

Vladimir